SLC1A5 and ovarian cancer: In this study, circ_0025033 knockdown repressed ovarian cancer cell proliferation, metastasis, angiogenesis, and glutamine metabolism and accelerated apoptosis through the hsa_miR-370-3p/SLC1A5 axis, which is expected to offer a promising treatment strategy for patients with ovarian cancer.